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Continuous ultraslow microdialysis and
ultrafiltration for subcutaneous sampling as






voorrang krijgen boven public
relations, want de natuur kan niet voor de gek
gehouden worden (Richard Feyman, Nobelprijswinnaar 1965).
                                                 




Classical microdialysis has some drawbacks. Two main issues in this respect are the
time consuming calculations (due to partial recovery of an analyte) and depletion near
the sampling site. In this paper we describe a new sampling method, called ultraslow
microdialysis (usMD), and compare this with ultrafiltration (UF) at flow rates between
100-300 nl min-1. For the usMD, the recovery at the applied flow rates was 100%. For
UF, the flow rates in vitro and in vivo were the same. As an example of an application
of this method, we conducted in a dual enzyme analysis for simultaneous measuring of
the glucose and lactate concentration using these sampling techniques in the
subcutaneous (sc) tissue of the rat. Both sampling techniques have the potential of
on-line in vivo monitoring, as well as the measurement of time profiles of analytes by
continuous collection and off-line analysis afterwards.
Introduction
Biochemical constituents in blood can serve as parameters for illness, drug metabolism
and regulation of homeostasis. Blood sampling and subsequent laboratory analysis is labour
intensive, patient unfriendly and often expensive. In vivo applied biosensors may overcome
many of these problems (Gilbert and Vender, 1996; Anderson et al., 1997). However, until
now, there are only few examples of such devices used (batch-wise) in clinical practice.
A problem of the biosensors placed in direct contact with the body is that they often evoke
a physical reaction, such as covering of the sensor with collagen (Reach and Wilson, 1992)
or, when placed in the blood stream, with fibrin (Ash et al., 1992). This creates an
additional diffusion barrier, which results in lower measured analyte concentrations
(Fischer et al., 1994). In addition, calibration of the sensor in-situ in man is often difficult.
Furthermore, a sensor placed in vivo often becomes unstable. Measurements with the sensor
in vivo are, therefore, often inaccurate (Pickup, 1993; Johne et al., 1995).
With microdialysis (MD), relatively clean samples can be obtained. MD is a dynamic
sampling method based on analyte diffusion across a semi-permeable membrane driven by
a concentration gradient. (Palmisano et al., 1997). MD probes have successfully been
applied in both laboratory animals and in man, for example in the brain (Kanthan et al.,
1995; Paez et al., 1996), subcutaneous tissue (Lonnroth et al., 1987; Arner et al., 1988) and
blood (Telting-Diaz et al., 1992; Stjernstrom et al., 1993; Chen and Steger, 1993; Paez and
Hernandez, 1997). A drawback of the MD technique is that calculation of the recovery in
vivo is difficult, labour intensive and often rather imprecise (Justice, Jr. 1993; Johne et al.,
1995). In addition, the sampling can lead to a local depletion of the analytes, because of a
removal of the analytes near the MD probe, which leads to an underestimation of the
concentrations (Petyovka et al., 1995). To reduce the drainage and to obtain a (near) 100%
recovery, the flow of the dialysis fluid has to be very low (less than 0.5 µl min-1 (Petyovka
et al., 1995)).
Recently (Moscone et al., 1996a; Kaptein et al., 1997a), we have introduced an on-line
ultrafiltration (UF) method as an alternative for continuous sampling. UF is a sampling
technique that withdraws fluid from the tissue through a semi-permeable membrane. Others
(Linhares and Kissinger, 1992; Linhares and Kissinger, 1993; Scheiderheinze and Hogan,
1996) have previously described UF for off-line analysis. The driving force in this process
is underpressure in the sampling tube, which creates an influx of extracellular fluid through
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the semi-permeable membrane of the probe. We have applied UF for subcutaneous and
intravenous sampling in rats with an ultra-slow continuous flow (100 nl min-1) in
combination with direct analysis of the glucose content (Moscone et al., 1996). Also, we
analysed a concentration profile in a continuously collected 24 hours sample (Kaptein et al.,
1997a). The underpressure was created with a disposable syringe, a monovette, with a fluid
restriction to ensure a constant flow over several hours.
When we tested the UF in sc tissue of healthy human volunteers (Tiessen et al., 1997),
we occasionally observed an additional resistance over the probe, leading to a decrease in
the flow rate. Even at flow rates as low as 100 nl min-1, there was insufficient formation of
the extracellular fluid. Therefore, in this study we investigated ultraslow microdialysis
(usMD) sampling in the subcutaneous tissue of the rat and compare the sampling with
ultrafiltration (UF). At flow rates between 100-300 nl min-1, we study the recovery of the
usMD, and for UF we evaluate resistance over the probe. We compared the sampling
techniques using a dual enzymatic analysis technique for glucose and lactate.
Material and methods
General description of the system
The experimental set-up of a measurement is shown schematically in Fig. 4.1. The
probe (for sampling) was coupled to a dual detection system, c sisting of an HPLC pump
(HPu), a splitter (S; 50-50% splitting ratio) and two enzyme reactors (L and G), both
upstream of an electrochemical detector (ECD1 and ECD2). One of the enzyme reactors
contained horseradish peroxidase, HRP and glucose oxidase, GOD, whereas the other


















Fig. 4.1. Schematic set-up of the dual enzyme UF/usMD system. BD: buffer detection unit; HPu: HPLC pump
detection unit; DBT: detection buffer tube; S: splitter; L: LOD/HRP enzyme reactor; G: GOD/HRP enzyme
reactor; ECD1,2: electrochemical detector; V: valve; SCT: sample connection tube; SWT: sample waste tube;





Our probe was a modified design of a previously described ultrafiltration probe
(Moscone et al., 1996; Kaptein et al., 1997). We used a four centimetre long probe from
semi-permeable membrane (fibers of an artificial kidney, AN69HF Filtral 16; Hospal Ind.,
Meyzieu, France, outer diameter = 290 µm, inner diameter = 240 µm) with a hand-made
spring inside (stainless steel wire; Vogelsang, Hagen, Germany; 60 µm diameter, axial
length 12 windings cm -1) to prevent collapsing of the fibre. This probe was connected on
both ends to a 20-30 cm long fused silica tube (inner diameter 50 µm, outer diameter = 150
µm, Applied Science Group, Emmen, The Netherlands). The spring was glued to the fused
silica tubes, and the connection of this with the fibre was closed with cyano-acrylic glue
(Henkel, Nieuwegein, The Netherlands). One end was screwed into the valve of the Trident
(Spark Holland, The Netherlands), the other end was closed (UF) or held in a PBS-buffer
(usMD). The UF or usMD flow (100-3  nl min-1) was driven by the underpressure of a
Hamilton syringe (0.5 ml) by pulling with the Harvard apparatus 22 syringe pump. The
valve, switched pneumatically by the Trident (load/inject 15/90 seconds), had a loop of 20
ml, which was only partially filled with the sample.
Glucose and lactate were detected electrochemically using bi-enzyme reactors as
described by Elekes et al. for glucose (Elekes et al., 1995). The flow injection system has
been described before by our group (Kaptein et al., 1997a). In brief, the buffer used for the
detection system is a ferrocene-PBS buffer, containing 137 mM NaCl, 2.7 mM K l, 8 mM
Na2HPO4, 2.5 mM KH2PO4. All the chemicals were of pro-analysis quality and were
purchased from Merck, Darmstadt, Germany. To this, 0.5 mM Ferrocenemonocarboxylic
acid, (Sigma Chemical Co, St. Louis, MO, USA) and 0.1 volume% Kathon CG (Rhom and
Haas, Croydon, UK) was added in double quarts distilled water. An HPLC pump (LKB
2150, Pharmacia Bromma, Sweden) pumped the ferrocene-PBS buffer (bubbled with
helium to remove air), with a flow of 0.25 ml min-1. This flow was divided in two separate
streams after the injection valve and each was pumped through the one enzyme reactor and
electrochemical cell. In the enzyme reactor for glucose, 250 U GOD (EC 1.1.3.4, grade I)
and 250 U HRP (EC 1.11.1.7), obtained from Boehringer Mannheim (Germany), was
immobilized between 0.01 µm cellulose nitrate filters (thickness 100 µm; pore size
0.01 µm, cut-off 50 kDa, Sartorius, Göttingen, Germany). The enzyme reactor for lactate
comprised of 25 U LOD and 250 U HRP. The electrochemical cells were thin layer-type
cells, with a glassy carbon working electrode hold at 0.00 mV relative to an Ag/AgCl
reference electrode and a Teflon/carbon counter electrode (Amor, Spark Holland, Emmen,
The Netherlands).
Theoretical considerations for the interpretation of the measurements
To explain the different interventions in the system and the effects from these on the
signal, we show a schematic representation of a recorder output for one analyte with these
changes (Fig. 4.2).
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Fig. 4.2. Schematic representation of the different interventions of an i  vivo experiment. A. probe in vitro;
B. probe in vivo; C. sc sample in detector; D. UF => usMD; E. usMD sample in detector; F. flow increase 2-fold;
G. high flow sample in detector See text for details.
At t=1, the measurement starts with analysing a buffer containing a certain
concentration of the analyte (glucose or lactate) with the detection system. In this
hypothetical case, we assume a start with UF. At t=2, the probe (Pr in Fig. 4.1) is
transferred from in vitro to subcutaneous tissue. The sample connection tube (SCT) is then
still filled with sample from the (in vitro) buffer. In case of any change in flow (e.g. as a
result of a restriction over the probe membrane), the signal will immediately change. At t=3
the sample of the subcutaneous tissue reaches the detector. In this case, the concentration of
the analyte is higher than in the previous buffer. At t=4, the fluid inlet (FI) for usMD is
opened, thus starting dialysis. Again, if this would influence the flow rate because of
restriction on the probe during UF, this would result in a change in signal. At t=5, the
usMD sample reaches the valve (V), thus injected and analysed. If the recovery of the
microdialysis is lower than 100%, the signal will decrease. At t=6, the flow is increased
two-fold. This leads to a two-fold increase of signal, if the signal increase has a linear
relationship with the sample amount. At t=6.5, the first sample from the higher flow
reaches V. Changes in recovery at the higher flow, will be shown at this time.
In vitro experiments
The calibration of the measurement was performed by placing a probe in the ferrocene
buffer with glucose concentrations of 0, 2.5, 7.5 and 10 mM, or lactate 0, 1, 2 and 4 mM,
was changed incrementally. The load/inject time was 15/90, therefore the sample was
measured every 105 seconds with the ECD and the currents (in nA) were recorded. The
calibration curve was made with UF and usMD, which determinedthe system delay (the
lag-time) that was caused by the volume of the connecting tube from the probe to the




Male Wistar rats (250-350 g, Harlan, Zeist, The Netherlands) were housed groupwise
on a 12-12h light/dark regime. Their food and drink were provided ad libitum. The rats
were anaesthetized by an intraperitonial (i.p.) injection of 6 mg kg -1 body wt pentobarbital
sodium (Sanofi, Maassluis, The Netherlands) and remained anaesthetized with these drugs.
Using a rectal temperature probe and a heat pad, t  body temperature was maintained
between 36.5 and 37.5 °C.
Before starting an in vivo experiment, the sensitivity of the system was determined in
vitro, using a buffer with 2.5 mM glucose and 1 mM lactate. The probe was placed in
sc tissue on the back of the rat with a 16G catheter needle. The flow of the sampling system
varied from 100-300 nl min-1 by changing the flow rate of the syringe pump (SP). The
probe was alternated between UF and usMD by blocking or unblocking the fluid inlet (FI)
with a stopper.
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Fig. 4.3. Calibration curves A. lactate, UF (r>0.99); B. lactate, usMD (r>0.98); C. glucose, UF (r>0.99);
D. glucose, usMD (r>0.99) n :100 nl min-1; l: 200 nl min-1;s: 300 nl min-1; _____: regression.




Fig. 4.3 shows the effect of a different flow rate on the electrochemical signal for
lactate (A&B) and glucose (C&D). For UF (Figs A&C) as well as usMD (Figs B&D) the
current was linearly correlated to the concentration of the analyte. The sensitivity for lactate
was 0.6 A mmol -1 for UF (r>0.99; p<0.000) and 0.01 A mmol -1 for usMD (r>0.98;
p<0.000). The difference in sensitivity for lactate with UF or usMD was caused by the
different enzyme activity. The enzyme activity for LOD, and therefore its electrochemical
signal, decreases considerably with time. However, the decrease during an (in vivo)
experiment was negligible, as checked with standards before and after the experiment.
For glucose, the sensitivit es were respectively 0.18 A mmol -1 (r>0.99; p<0.000) and
0.12 A mmol-1 (r>0.99; p<0.000). The curve remained linear for all curves for the applied
amounts from 0-350 pmol for lactate and 0-750 pmol for glucose.
In vivo experiments
Fig. 4.4 shows representative data of a measurement in the sc tissue of a rat. As was
indicated, the flow was continuously changing and the sampling method (usMD or UF) was
alternating. The transition from UF to usMD and vice versa did not change a signal either
directly or after the delay caused by the volume of the SCT. This implies that the UF
sampling does not have a significant restriction over the probe and that the recovery for this
in vivo usMD at the applied flow rates is 100%. There was some slight fluctuation in the
flow, which can be seen when both analytes fluctuate simultaneously, e.g. at time interval
II. This is often seen as a result of irregularities of the pumping system under these
extremely low flow conditions. Sometimes, a decrease in flow at UF occurred at the highest
flow (300 nl min-1) as a result of the resistance over the membrane of the probe (data not
shown).
When the signals for different flows (in vitro) were calculated, it appeared that a
certain amount of fluid leaked, probably in the valve. This can be seen in Fig. 4.5, when the
average of three measurements of glucose before and after a change of flow rate is
calculated. The leakage is equivalent to 60 nl min-1, thus with the 15 seconds load this
would mean 15 nl per injection. The standard curves shown in Fig. 4.3 did not show this,
because at that time the valves did not leak. Correction for this leakage did not influence
the results. The concentration of glucose and lactate in the rat during the experiment is
shown in Fig. 4.5. The glucose concentration is quite constant, whereas the lactate
concentration fluctuates with a trend to lower values.
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Fig. 4.4. Example of dual enzyme UF/usMD measurement in vivo for lactate (upper) and glucose (lower).
Indicated are: a: probe in UF sampling placed in buffer solution with 2.5 mM glucose and 1 mM lactate; b: probe
placed in sc tissue of rat; c: UF sample in detection unit; d: transition UF => usMD; e: flow increase from
100 nl min-1 => 200 nl min-1; f: transition usMD => UF; g: flow increase from 200 nl min-1 => 300 nl min-1;
h: transition UF => usMD; I: lag-time; II: see text.
Discussion
In the present study, we demonstrated a system for UF and usMD with different flow
rates. To illustrate its application, we coupled the sampling system to a dual enzyme
detection system, analysing glucose and lactate simultaneously in one continuous sample in
a flow injection analysis system with a splitter. The splitter volume ratio can be changed,
and the amount of enzyme in the reactors and the sample volumes injected can also be
adjusted. This allows for simultaneous analysis of other constituents, even if different
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substrates are added or if sample sizes and sensitivities are different. Leakage in the valve
connection must be reduced for these low flows. In combination with a collection tube, as
described earlier, profiles can collected and analysed afterwards in laboratory conditions for
any analyte, as long as there is an assay with enough sensitivity.

















































Fig. 4.5. Calculated lactate and glucose concentrations for recorder output of Fig. 4.4. Window: response at
different flow rates for glucose in vivo.
The main study object of this research was the comparison of our new continuous
sampling system (the ultraslow microdialysis, usMD) to ultrafiltration. By repetitive
switches from usMD and ultrafiltration and vice versa, we were able to demonstrate a
100% recovery for this usMD under the applied conditions. We also showed that the
UF sampling in the interstitial fluid in the back of the rats can be realized with a flow of
200 nl min-1, and in most cases, such as in the given example, this flow was realized up to
300 nl min-1. As mentioned in the introduction, these findings may be different when the
UF technique is used in abdominal tissue in human subjects. When the flow is not
measured, correction is difficult.
In the present study, we used a syringe pump, allowing flow changes during the
experiment. Unfortunately, at these low flow rates this pump showed some flow
disturbances as a result of pulsation caused by the moving parts in the pump. Previously
(Moscone et al., 1996; Kaptein et al., 1997), we described a more precise, inexpensive
pumping system for fixed ultraslow flow rates: a monovette who’s driving force comes
from an underpressure and a flow regulation by a fused silica restriction. For the present
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experiment this was not utilized because changes of the flow rate are difficult to achieve
with this pump.
The low flows for both UF as well as usMD have several advantages. The intervention
of the tissue (fluid) around the probe is reduced, because of the small amount of the fluid or
analytes removed. In addition, we demonstrated that for usMD the recovery of glucose and
lactate is 100% at the applied probe size and flow rates. Labour-intensive, inaccurate
recovery calculations are therefore not necessary.
Whether usMD or UF is the best option depends on the in vivo application. Both
techniques can use disposable material, and both can create the relatively clean samples
with (for small analytes) a 100 % recovery. UsMD is the best choice when the amount of
fluid at the sampling site is limited. We noticed that in the brain of a rat and in
subcutaneous tissue of humans, an in vitro flow rate of 100 nl min-1 is lower in vivo because
of a restriction over the membrane of the probe. The exact concentration is then difficult to
estimate. The drawback of the usMD technique is the necessity of an additional fluid,
making it more difficult to keep the sampling system sterile (especially because the flow is
created by the underpressure of the monovette “pump”). When, for example, a 24 hour
profile of an analyte of an ambulant patient has to be made, UF will give less risks on
infection, so if a constant flow can be created, this is the method of choice. However, when
the sampling site is very limited in fluid production, usMD is preferable.
The described usMD and UF techniques can be integrated in many selection and
detection systems. Selection can be performed in flow injection systems. The undiluted
samples can then be separated with microtechniques, such as capillary electrophoresis
(Hadwiger et al., 1997; Dawson et al., 1997) and microbore HPLC (Steele and Lunte,
1995). The absence of large molecules enables direct analysis. Selection can also be
performed with enzymes creating products from the analyte which are detectable. An
example for this is the enzymatic conversion of glucose into (among other) hydrogen
peroxide, an electrochemical detectable compound (Fang et al., 1997; Anderson et al.,
1997). This enzymatic reaction is often used in biosensors. Other biosensor selection
devices are based on immunological reactions (Morgan et al., 1996b; Kaptein et al., 1997b).
Biosensors might better function in UF/usMD sampling devices than in direct contact with
the body, because of the relatively “clean” sample, whereas calibration (because of the
100% recovery) is easier than in MD sampling with µl min-1 flow rates. The total
integration of the sampling, selection and detection in on-line biosensors, as demonstrated
by Rigby et al. (1996), using a cheap, pulse-free pumping system as we described earlier
(Moscone et al., 1996a; Kaptein et al., 1997a) enables on-line bedside measurements.
In summary, we described a sampling probe for ultraslow microdialysis or
ultrafiltration. With simultaneous glucose and lactate analysis, we demonstrated a
100% recovery for microdialysis in vivo in subcutaneous tissue of the rat at a flow rate of
100-300 nl min-1. No restriction over the probe was encountered at UF sampling up to at
least 200 nl min-1. Both sampling techniques enable on-line in vivo measurements as well as
sample collection to study time profiles of various compounds by subsequent analysis of
the collected sample and can be combined with several microanalysis systems.
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